Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Alaska

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Alaska. What Alaska requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Alaska at a glance

Pharmacy regulator
Alaska Board of Pharmacy
503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Alaska

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Alaska (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Alaska

AS 08.02.130, added by HB 265 in 2022, lets a health care provider licensed in Alaska treat a patient in Alaska through telehealth without first conducting an in-person visit. AS 08.64.364 bars the State Medical Board from disciplining a physician or physician assistant for prescribing a non-controlled drug without a physical examination if follow-up care is available and the prescriber asks the patient for consent to send the encounter records to the patient's primary care provider. The same section says a physician or physician assistant may not prescribe in response to an Internet questionnaire or electronic mail message to a person with whom there is no prior physician-patient relationship. Board regulation 12 AAC 40.943 adopts two documents as the standard of practice for prescribing without an in-person exam: the guiding principles in American Medical Association Council on Medical Service Report 7 (A-14) and the Federation of State Medical Boards' April 2014 model telemedicine policy. The model policy lets the relationship be formed through telemedicine technologies if the standard of care is met and says a prescription based solely on an online questionnaire is not acceptable. The AMA report says a valid patient-physician relationship must be established through a face-to-face examination where one would otherwise be required, and that this encounter can occur in person or through real-time audio and video technology. A prescriber generally needs an Alaska license (AS 08.02.130(b) admits out-of-state physicians only for narrow follow-up and life-threatening-condition cases), and any business delivering telehealth to Alaska patients must register on the Telemedicine Business Registry. This record leaves asynchronous prescribing unclassified because the law is ambiguous: the two adopted standards point in different directions, no Alaska statute or regulation names asynchronous or store-and-forward evaluation as enough to prescribe, and the statute bars questionnaire or email prescribing to a new patient. [5] [6] [7] [8] [9]

Compounded GLP-1 access in Alaska

Because Alaska now requires a full pharmacy license for any out-of-state pharmacy, Alaska patients using telehealth GLP-1 programs should confirm the dispensing pharmacy appears in the Division's professional license search as an Alaska-licensed pharmacy. [1] [2] [11]

Research use only sellers in Alaska

Any entity distributing prescription drugs into Alaska must be licensed by the Board of Pharmacy under AS 08.80.157, and peptides sold "for research use only" but marketed for human injection are unapproved new drugs under 21 U.S.C. 331 regardless of labeling. These products are not dispensed by a pharmacist, are not covered by Alaska's Telemedicine Business Registry protections, and carry no state consumer safeguards. [2] [12]

How to check a telehealth provider in Alaska

  1. Confirm the prescriber is licensed or registered to treat patients located in Alaska; the telehealth rules above explain what Alaska requires. [5] [6] [7] [8] [9]
  2. Ask which pharmacy will fill the prescription and check it in the Alaska Board of Pharmacy license lookup. [1] [2] [3] [4] [10]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Alaska. [2] [12]

Common questions in Alaska

Can I get a GLP-1 prescription in Alaska through telehealth without a physical exam?

Yes. AS 08.64.364 protects an Alaska-licensed physician or physician assistant from Board discipline for prescribing a non-controlled drug without a physical examination if follow-up care is available and the prescriber asks for your consent to send the records to your primary care provider. AS 08.02.130 lets Alaska-licensed providers treat patients by telehealth without a first in-person visit. Semaglutide and tirzepatide are not controlled substances. AS 08.64.364 also bars prescribing to a new patient in response to an internet questionnaire or email. Alaska law does not settle whether an evaluation with no live visit is enough, because the two practice standards the Board has adopted point in different directions. [5] [7] [8]

Does an out-of-state telehealth clinic need an Alaska license to treat me?

Generally yes. The provider must hold an Alaska license from the relevant board, and the business must be listed on Alaska's Telemedicine Business Registry. AS 08.02.130(b) lets a physician licensed in another state provide telehealth only in narrow cases: follow-up care for an established patient the physician has seen in person, a referred visit about a life-threatening condition, and ongoing care for a life-threatening condition. [6] [7]

All peptide legal questions for Alaska

Sources

  1. [1]Alaska Board of Pharmacy (Division of Corporations, Business and Professional Licensing)
  2. [2]Alaska Board of Pharmacy: statutes and regulations (AS 08.80 and 12 AAC 52, including the 2023 pharmacy licensing changes)
  3. [3]12 AAC 52.440, Guidelines relating to compounding practices
  4. [4]Alaska Legislature, Alaska Administrative Code: 12 AAC 52.430 (sterile pharmaceuticals) and 12 AAC 52.440 (compounding practices), accessed 2026-09-22
  5. [5]Alaska Statutes AS 08.64.364, Prescribing without a physical examination (telehealth), accessed 2026-09-30
  6. [6]Alaska Division of Corporations, Business and Professional Licensing: telehealth information and Telemedicine Business Registry (AS 08.02.130)
  7. [7]Alaska Statutes AS 08.02.130, Telehealth (added by HB 265, 2022; amended by SB 91, 2024), accessed 2026-09-30
  8. [8]12 AAC 40.943, Standards of practice for telemedicine (adopts AMA Council on Medical Service Report 7 (A-14) and the FSMB April 2014 model policy; subsection (b) repealed effective July 4, 2026), accessed 2026-09-30
  9. [9]Alaska Online Public Notices: State Medical Board regulations re: Telemedicine Standards of Practice (12 AAC 40.943), filed June 4, 2026, effective July 4, 2026
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts